Acute promyelocytic leukemia in the course of acromegaly: A case report

Endocrine Journal

Volumn 43, Issue 5, 1996, Pages 565-568

  Beyan, Cengiz ^a   Ural, A Uǧur ^a   Çetin, Türker ^a   Özata, Metin ^a   Yalçin, Atilla ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acromegaly; Acute promyelocytic leukemia

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; DOPAMINE RECEPTOR STIMULATING AGENT; DOXORUBICIN; FOLLITROPIN; GROWTH HORMONE; HEMOGLOBIN; HLA DR ANTIGEN; HYDROCORTISONE; LIOTHYRONINE; LISURIDE MALEATE; LUTEINIZING HORMONE; MICROSOMAL AMINOPEPTIDASE; OCTREOTIDE; PROLACTIN; THYROTROPIN; THYROXINE; TIOGUANINE;

ACROMEGALY; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOPHENOTYPING; INTRAVENOUS DRUG ADMINISTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION;

EID: 0029911946     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.43.565     Document Type: Article

References (27)

1. Barzilay J, Heatley GJ, Cushing GW (1991) Benign and malignant tumors in patients with acromegaly. Arch Intern Med 151: 1629-1632.
2. Bengtsson BA, Eden S, Ernest I, Oden A, Sjögren B (1988) Epidemiology and long-term survival in acromegaly. Acta Med Scand 223: 327-335.
3. Blatt J, Penchansky L, Phebus C, Horn M (1991) Leukemia in a child with a history of medulloblastoma. Pediatr Hematol Oncol 8: 77-82.
4. Brock PR, De Zegher F, Casteels-Van Daele M, Vanderschueren-Lodeweyckx M (1991) Malignant disease in Bloom's syndrome children treated with growth hormone. Lancet 337: 1345-1346.
5. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, Mellinger RC (1990) Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer. Clinical Endocrinology 32: 65-71.
6. Buchanan CR, Preece MA, Milner RD (1991) Mortality, neoplasia, and Creutzfeldt-Jakop disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ 302(6780):824-828.
7. Daughaday WH (1990) Editorital: The possible autocrine paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127 (1): 1-4.
8. Estrov Z, Meir R, Barak Y, Zaizov R, Zadik Z (1991) Human growth hormone and insulin-like growth factor-I enhance the proliferation of human leukemic blasts. J Clin Oncol 9 (3): 394-399.
9. Ezzat S, Melmed S (1991) Clinical review 18 are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 72 (2): 245-249.
10. Fradkin JE, Mills JL, Schonberger LB, Wysowski DK, Thomson R, Durako SJ, Robison LL (1993) Risk of leukemia after treatment with pituitary growth hormone. JAMA 270 (23): 2829-2832.
11. Hagg E, Asplund K, Holm J (1988) Acromegaly and multiple myeloma. Annals of Internal Medicine 110: 437-438.
12. Hintz RL (1992) Untoward events in patients treated with growth hormone in the USA. Horm Res 38 (Suppl 1): 44-49.
13. Ishii A, Kakuta K, Tsuchiya S, Konno T (1989) Chronic myelocytic leukemia probably promoted by growth hormone. Tohoku J Exp Med 158 (3): 263-264.
14. Ituarte EA, Petrini J, Hershman JM (1984) Acromegaly and colon cancer. Annals of Internal Medicine 101: 627-628.
15. Klein I (1984) Acromegaly and cancer. Annals of Internal Medicine 101 (5): 706-707.
16. Merchav S, Tatarsky I, Hochberg Z (1988) Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/Somatomedin C and human growth hormone. J Clin Invest 81: 791-797.
17. Nabarro JDN (1987) Acromegaly. Clinical Endocrinology 26: 481-512.
18. Ogilvy-Stuart AL, Shalet SM (1992) Tumor occurrence and recurrence. Horm Res 38 (Suppl 1): 50-55.
19. Pepe M, Ginzton N, Lee P, Hintz RL, Greenberg PL (1986) Insulin and insulin-like growth factor receptors on human myeloid leukemic cells. Exp Hematol 14: 428.
20. Ritzen EM (1993) Does growth hormone increase the risk of malignancies? Horm Res 39: 99-101.
21. Sinclair J, McClain D, Taetle R (1988) Effects of insulin and insulin-like growth factor I on growth of human leukemia cells in serum-free and protein-free medium. Blood 72: 66-72.
22. Standen GR, Hughes IA, Geddes AD, Jones BM, Wardrop CAJ (1989) Melodysplastic syndrome with trisomy 8 in an adolescent with fanconi anaemia and selective IgA deficiency. Am J Hematol 31:280-283.
23. Stahnke N, Zeisel HJ (1989) Growth hormone therapy and leukemia. Eur J Pediatr 148(7): 591-596.
24. Stahnke N (1992) Leukemia in growth-hormone-treated patients: An update, 1992. Horm Res 38 (Suppl): 56-62.
25. Watanabe S, Tsunematsu Y, Fujimoto J, Komiyama A (1988) Leukemia in patients treated with growth hormone. Lancet i: 1159.
26. Watanabe S, Mizuno S, Oshima LH, Tsunematsu Y, Fujimoto J, Komiyama A (1993) Leukemia and other malignancies among growth hormone users. J Pediatr Endocrinol 6 (1): 99-108.
27. Zadik Z, Estrov Z, Karov Y, Hahn T, Barak Y (1993) The effect of growth hormone and insulin-like growth factor-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission. A preliminary report. J Pediatr Endocrinol 6(1): 79-83.